These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 32156603

  • 21. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

  • 22. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC, Liang CD, Wang CL, Yu HR, Hwang KP, Yang KD.
    Acta Paediatr; 2010 Oct; 99(10):1578-83. PubMed ID: 20491705
    [Abstract] [Full Text] [Related]

  • 23. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
    Ge X, Li CR, Yang J, Wang GB.
    Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
    [Abstract] [Full Text] [Related]

  • 24. [Role of ash2 (absent, small, or homeotic)-like and Jumonji domain-containing protein 3 on histone methylation of interferon-gamma gene and their associations with vascular damage of Kawasaki disease].
    Mei JH, Tang G, Wang Q, Wen PQ, Xu MG, Cui D, Ma DL, Liu C, Wang GB.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Sep 24; 45(9):791-798. PubMed ID: 29036979
    [Abstract] [Full Text] [Related]

  • 25. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
    Turk J Pediatr; 2019 Sep 24; 61(5):648-656. PubMed ID: 32104995
    [Abstract] [Full Text] [Related]

  • 26. Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients.
    Zhang R, Shuai S, Zhang H, Cai J, Cui N, Tang M, Xing S, Gao Y, Liu X, Yang X.
    Ital J Pediatr; 2023 Jun 25; 49(1):78. PubMed ID: 37357258
    [Abstract] [Full Text] [Related]

  • 27. Decreased levels of inflammatory cytokines in immunoglobulin-resistant Kawasaki disease after plasma exchange.
    Fujimaru T, Ito S, Masuda H, Oana S, Kamei K, Ishiguro A, Kato H, Abe J.
    Cytokine; 2014 Dec 25; 70(2):156-60. PubMed ID: 25082649
    [Abstract] [Full Text] [Related]

  • 28. Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China.
    Li G, Wang T, Gou Y, Zeng R, Liu D, Duan Y, Liu B.
    Int Immunopharmacol; 2020 Dec 25; 89(Pt A):107037. PubMed ID: 33242833
    [Abstract] [Full Text] [Related]

  • 29. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
    Chen MR, Kuo HC, Lee YJ, Chi H, Li SC, Lee HC, Yang KD.
    Front Immunol; 2021 Dec 25; 12():632890. PubMed ID: 33732254
    [Abstract] [Full Text] [Related]

  • 30. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
    Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
    [Abstract] [Full Text] [Related]

  • 31. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease.
    Duan Y, Li H, Luo D, Jiang J, Liu B, Li G.
    Int Immunopharmacol; 2023 Sep 21; 122():110600. PubMed ID: 37423157
    [Abstract] [Full Text] [Related]

  • 32. Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease.
    Si F, Wu Y, Gao F, Feng S, Liu R, Yi Q.
    Clin Exp Med; 2017 Nov 21; 17(4):451-457. PubMed ID: 28108813
    [Abstract] [Full Text] [Related]

  • 33. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children.
    Wu S, Liao Y, Sun Y, Zhang CY, Zhang QY, Yan H, Qi JG, Liu XQ, Chen YH, Wang YL, Li XY, Jin HF, Du JB.
    World J Pediatr; 2020 Dec 21; 16(6):607-613. PubMed ID: 32232677
    [Abstract] [Full Text] [Related]

  • 34. Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China.
    Huang H, Jiang J, Shi X, Qin J, Dong J, Xu L, Huang C, Liu Y, Zheng Y, Hou M, Shen Q, Zeng B, Qian G, Yang F, Lv H.
    Ann Med; 2022 Dec 21; 54(1):442-453. PubMed ID: 35099338
    [Abstract] [Full Text] [Related]

  • 35. Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease.
    Lu Y, Chen T, Wen Y, Si F, Wu X, Yang Y.
    BMC Pediatr; 2021 Sep 16; 21(1):406. PubMed ID: 34530763
    [Abstract] [Full Text] [Related]

  • 36. Changes in Peripheral Blood Neutrophils, Lymphocytes and IL-10 in Children with Kawasaki Disease from Different Age Groups Undergoing Intravenous Immunoglobulin: A Retrospective Study.
    Zhang C, Zhang X, Shen J, Lu X, Zhang J, Chen S.
    Mediators Inflamm; 2020 Sep 16; 2020():5213451. PubMed ID: 33293897
    [Abstract] [Full Text] [Related]

  • 37. Marker of T-cell activation is elevated in refractory Kawasaki disease.
    Suzuki H, Suenaga T, Takeuchi T, Shibuta S, Yoshikawa N.
    Pediatr Int; 2010 Oct 16; 52(5):785-9. PubMed ID: 20487370
    [Abstract] [Full Text] [Related]

  • 38. Kawasaki disease in Sicily: clinical description and markers of disease severity.
    Maggio MC, Corsello G, Prinzi E, Cimaz R.
    Ital J Pediatr; 2016 Nov 02; 42(1):92. PubMed ID: 27806720
    [Abstract] [Full Text] [Related]

  • 39. Predictive value of C-reactive protein to albumin ratio as a biomarker for initial and repeated intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients: a prospective cohort study.
    Liu X, Wang L, Zhou K, Shao S, Hua Y, Wu M, Liu L, Wang C.
    Pediatr Rheumatol Online J; 2021 Mar 12; 19(1):24. PubMed ID: 33712036
    [Abstract] [Full Text] [Related]

  • 40. Analysis of biomarker serum levels in IVIG and infliximab refractory Kawasaki disease patients.
    Hachiya A, Kobayashi N, Matsuzaki S, Takeuchi Y, Akazawa Y, Shigemura T, Motoki N, Masumoto J, Agematsu K.
    Clin Rheumatol; 2018 Jul 12; 37(7):1937-1943. PubMed ID: 29302828
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.